Proteogenomics: advances in cancer antigen research

• Main Authors: Takayuki Kanaseki, Toshihiko Torigoe
• Format: Article
• Language: English
• Published: Taylor & Francis Group 2019-04-01
• Series: Immunological Medicine
• Subjects: Cancer antigen; HLA; CTL; immunotherapy
• Online Access: http://dx.doi.org/10.1080/25785826.2019.1640500

T cells recognize antigen peptides displayed by HLA molecules and specifically eliminate their target cells. Identification of responsible antigens as well as understanding the mechanism by which antigens are produced inside cells are equally crucial for cancer immunology. In this review, we introduce proteogenomics and its applications in cancer antigen research, which leverages mass spectrometry and next-generation sequencing. The approach comprehensively captures immunopeptidome displayed by HLA, revealing new classes of antigens, such as mutation-derived neoantigens, spliced peptides, and non-coding region derived peptides. These antigens may serve as therapeutic targets or biomarkers. Thus, proteogenomics is a promising approach for cancer antigen research and contributes to immunotherapy development.